The domain of therapeutics focused on CD47 targeting is rapidly emerging as a foundational pillar of next-generation cancer immunotherapy. CD47, a protein universally expressed on healthy cells, acts as a "don't eat me" signal when it binds to the SIRP-alpha receptor on immune cells like macrophages. Cancer cells frequently overexpress CD47 to exploit this pathway, allowing them to evade the...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
thai 
English
French
Spanish
Portuguese
Italiano
Romaian
Portuguese (Brazil)
china